These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14698546)

  • 1. Reply to "Radiation pneumonitis and docetaxel".
    Senan S
    Lung Cancer; 2004 Jan; 43(1):117-8; author reply 119-20. PubMed ID: 14698546
    [No Abstract]   [Full Text] [Related]  

  • 2. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.
    Onishi H; Kuriyama K; Yamaguchi M; Komiyama T; Tanaka S; Araki T; Nishikawa K; Ishihara H
    Lung Cancer; 2003 Apr; 40(1):79-84. PubMed ID: 12660011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional radiotherapy and docetaxel in treatment of stage III non-small cell lung carcinoma: no good survival due to radiation pneumonitis.
    Dinçbas FO; Atalar B; Koca S
    Lung Cancer; 2004 Feb; 43(2):241-2. PubMed ID: 14739045
    [No Abstract]   [Full Text] [Related]  

  • 4. Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study.
    Maggi G; Casadio C; Cianci R; Oliaro A; Molinatti M; Bretti S; Clerico M; Boidi-Trotti A; Rovea P
    J Cardiovasc Surg (Torino); 1994 Aug; 35(4):341-6. PubMed ID: 7929550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
    Jain AK; Hughes RS; Sandler AB; Dowlati A; Schwartzberg LS; Dobbs T; Schlabach L; Wu J; Muldowney NJ; Choy H
    J Thorac Oncol; 2009 Jun; 4(6):722-7. PubMed ID: 19404213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of pemetrexed and cisplatin, with chest radiotherapy followed by docetaxel in patients with stage III non-small cell lung cancer.
    Gadgeel SM; Ruckdeschel JC; Patel BB; Wozniak A; Konski A; Valdivieso M; Hackstock D; Chen W; Belzer K; Burger AM; Marquette L; Turrisi A
    J Thorac Oncol; 2011 May; 6(5):927-33. PubMed ID: 21415776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients.
    Werner-Wasik M; Scott C; Graham ML; Smith C; Byhardt RW; Roach M; Andras EJ
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):327-31. PubMed ID: 10760427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer.
    Font A; Arellano A; Fernández-Llamazares J; Casas D; Boix J; Cardenal J; Margelí M; Manzano JL; Abad A; Rosell R
    Clin Transl Oncol; 2007 Mar; 9(3):177-82. PubMed ID: 17403629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
    Le Chevalier T; Arriagada R; Quoix E; Ruffie P; Martin M; Douillard JY; Tarayre M; Lacombe-Terrier MJ; Laplanche A
    Lung Cancer; 1994 Mar; 10 Suppl 1():S239-44. PubMed ID: 8087515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy.
    Holgersson G; Bergström S; Liv P; Nilsson J; Edlund P; Blomberg C; Nyman J; Friesland S; Ekman S; Asklund T; Henriksson R; Bergqvist M
    Anticancer Res; 2015 Oct; 35(10):5491-7. PubMed ID: 26408714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.
    Chhajed PN; Baty F; Pless M; Somandin S; Tamm M; Brutsche MH
    Chest; 2006 Dec; 130(6):1803-7. PubMed ID: 17167000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma.
    Koukourakis MI; Bahlitzanakis N; Froudarakis M; Giatromanolaki A; Georgoulias V; Koumiotaki S; Christodoulou M; Kyrias G; Skarlatos J; Kostantelos J; Beroukas K
    Br J Cancer; 1999 Aug; 80(11):1792-6. PubMed ID: 10468298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
    Weiss GJ; Vokes EE; Bunn PA; Magree L; Rusk J; Albert D; Kelly K
    J Thorac Oncol; 2007 Oct; 2(10):933-8. PubMed ID: 17909356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.
    Niu X; Li H; Chen Z; Liu Y; Kan M; Zhou D; Li Z; Ye X; Shen S; Lv C; Lu S
    J Thorac Oncol; 2012 Nov; 7(11):1668-75. PubMed ID: 23059779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to treatment in patients with stage III non-small cell lung cancer.
    Wang L; Correa CR; Hayman JA; Zhao L; Cease K; Brenner D; Arenberg D; Curtis J; Kalemkerian GP; Kong FM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):790-5. PubMed ID: 19231108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
    Filipazzi V; Cattaneo MT; Rho B; Frontini L; D'Adda D; Isa L; Scapaticci R; Legnani W; Calzavara MP; Berni F
    Oncology; 1993; 50(1):10-3. PubMed ID: 8380632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancer.
    Fujimoto N; Kiura K; Takigawa N; Fujiwara Y; Toyooka S; Umemura S; Tabata M; Ueoka H; Tanimoto M
    Acta Med Okayama; 2010 Feb; 64(1):33-7. PubMed ID: 20200582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy.
    Kotsakis A; Matikas A; Koinis F; Kentepozidis N; Varthalitis II; Karavassilis V; Samantas E; Katsaounis P; Dermitzaki EK; Hatzidaki D; Mavroudis D; Georgoulias V
    Br J Cancer; 2016 Sep; 115(7):784-8. PubMed ID: 27607471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 2 study of concurrent cetuximab plus definitive thoracic radiation therapy followed by consolidation docetaxel plus cetuximab in poor prognosis or elderly patients with locally advanced non-small cell lung cancer.
    Dilling TJ; Extermann M; Kim J; Thompson LM; Yue B; Stevens CW; Antonia S; Gray J; Williams C; Haura E; Pinder-Schenck M; Tanvetyanon T; Kim S; Chiappori A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):828-33. PubMed ID: 25216856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.